ENA0000GenomicsMolecular Endocrinology, Novo Nordisk foundation center for protein research, University of copenhagenhttps://www.ebi.ac.uk/ena/browser/view/PRJNA223238Homo sapiensLNCaP cells were transfected with 3 different REST siRNAs Transcriptomics analysis was performed to compare gene expression changes induced by REST knockdown Overall design: Genome-wide transcriptomic analysis of LNCaP cells transfected with REST siRNAENAAA407358, hereditary prostate cancer, LNCaP, cancer of the prostate, dTAF[[II]]230, TAF[[II]]250, d230, prostatic neoplasm, prostatic cancer, grupo, tumor of the prostate, carcinoma of prostate gland, familial, 2610008J04Rik, LNCAP cell, TAF200, TelN, malignant prostate gland neoplasm, carcinoma of the prostate, l(3)84Ab, dTAFII250, BG:DS00004.13, TAFII-250, NGP - new growth of prostate, TAF250/230, EfW1, Cell, group, dTAF230, prostate gland carcinoma, dmTAF[[II]]230, LNCAP, cancer of prostate gland, TAFII250, malignant prostate neoplasm, XBR, dmTAF1, Taf230, p230, malignant tumor of prostate, malignant neoplasm of prostate gland, TAF[[II]]250/230, TFIID, NRSF, NOS, tumour of the prostate, prostate neoplasm, prostate carcinoma, TAF250, malignant neoplasm of the prostate, malignant prostate tumor, Taf[[II]]250, Taf200, dTAF[[II]]250, TAF[[II]]230, TFIID TAF250, cel, Rests, cell, Rest, malignant tumour of prostate, Taf1p, TAF[II]250, CG17603, cancer of prostate, TAF[[II]], carcinoma of prostate, malignant tumour of the prostate, malignant neoplasm of prostate, dTAF250, DmelCG17603, TAF1., Taf250, grupos, malignant prostate tumour, SR3-5, ResT, prostate cancer, prostate gland cancer, PC, TAF, groupe, malignant tumor of the prostate, TAF230, Gruppehuman being, human., man0.00.00.00.00.00falseHomo sapiensREST knockdown in LNCaP prostate cancer cells2022-07-192014-02-11PRJNA223238GSE514619606